Published in Pharma Law Weekly, August 17th, 2004
Late last year, Exeter bought the patent on the technology used to clone the world's first sheep, Dolly, from PPL Therapeutics.
The company is actively looking for other important intellectual property in plant and animal biotechnology.
Exeter's other biotech holdings include ViaGen, Inc., an animal genomics and livestock cloning firm, and Arcadia BioSciences, a plant biotech company focused on using new technologies to find solutions to environmental problems.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.